Shelf-stable formulation of glucagon-like peptide-1

Details Shelf-stable formulation of glucagon-like peptide-1 Shelf-stable formulation of glucagon-like peptide-1

A - Human Necessities

61

K

A61K 38/26 (2006.01) A61K 38/28 (2006.01) A61K 47/10 (2006.01) A61K 47/26 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2358107

Glucagon-like peptide-1 (GLP-1) has been shown to be useful in the treatment of diabetes. The invention encompasses a shelf stable formulation that comprises a therapeutically effective amount of GLP-1, a pharmaceutically acceptable preservative, and a tonicity modifier, and that has a pH between about 8.2 to about 8.8.

On a démontré que le peptide-1 de type glucagon (GLP-1) est efficace dans le traitement du diabète. Cette invention concerne une formulation de longue conservation contenant une dose efficace du point de vue thérapeutique de GLP-1, un conservateur acceptable sur le plan pharmaceutique, un modificateur de tonicité, et présentant un pH compris entre environ 8,2 et environ 8,8.

Affiliated with

Also associated with

Rating

Shelf-stable formulation of glucagon-like peptide-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Shelf-stable formulation of glucagon-like peptide-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Shelf-stable formulation of glucagon-like peptide-1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1557877